Ci Canadian Bond Corporate Class Class P shares U Nl (CBTGX) Cotización

That is still the "In Press, Corrected Proof"!

What are corrected proofs?
Corrected proofs are Articles in Press that contain the author’s corrections. Final citation details (e.g., volume and/or issue number, publication year, and page numbers) still need to be added and the t

This week has started as a clone of the past 3 years. This ticker stuck at worthless, with a little up & down action to trips 1 and back down again.
Behind the scenes scenarios and predictions mean nothing...unless the news comes from the great CEO himself. But, he can't even file fins on tim

$ILLR Many Reasons To Like Triller Now!

~ Launch of Triller 5.0 App.
~ New Streaming Acquisition News Soon
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal court just upheld

💎 $ILLR Many Reasons To Like Triller Now⬇️

~ Launch of Triller 5.0 App.
~ New Streaming Acquisition News Soon
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal cour

Wow! I had no idea the JPM conference in San Francisco is as energetic as this link reads, including the partnership announcements. Will be fun to see how Anavex is positioned. The conference supposed to generate $92M for the city.
https://www.fiercebiotech.com/biotech/jpm25-day-1-fierce-bio

Truist Securities raises PT to $180 from $150 😮
The next two weeks will be eventful
AXS-07, a candidate for the acute treatment of migraines, with expectations for regulatory approval
NDA for AXS-14 for fibromyalgia... maybe yes or maybe no

https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amarin-pharma-inc/?page=2
Sleven,

"Right news" gonna get $175-350MM market cap? LOL!

Omg what a maroon.

Nice and interesting analysis, but completely irrelevant >!

I fed ChatGPT the following five comments regarding this analysis and it disagrees with you.

I saw these comments regarding how MHRA approves or rejects medecines at mhra meetings

1

MTC back to $96,000 after hitting $89, 200s yesterday. Cryptos I added to in the last couple of days were BOBO, PAI, OTTO and CLUSTR. RING AI looking better. Boom or bust for me.

Loading Zone Here! $ASII

Where is the CSE press release filing?

TWOH has been halted for more than a week now and the CSE press release is still missing.

Could the run up before the halt be the problem?

Could some people have been tipped off before the run up?

Coul

https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/473323273_992397186268896_4170433101098362110_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=833d8c&_nc_ohc=UebR9WKXEXsQ7kNvgELlMGV&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=AvB9U-Cb1bfWGguzkXzMzar&oh=00_AYDqG-tA0ScuUz90hSjz11X1LQL5aezyuhOfdBXmp9pGuQ&oe=678C04

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652942 I Miss Real

NEUK201-00* is being tested in advanced/metastatic solid tumours at a single site.

https://i.postimg.cc/fyWcxcwj/download.png

* It could be an iNK with just a high-affinity non-cleavable CD16(a) receptor, but this comes from a Chinese site that has under

I was just thinking the same thing

Go bother those serial OTC stock hijackers
( we know them all well ) that’s been doing LOI mergers, asset ( no asset ) transfers for years with never a real company.
( not you Prophet, to the shills )
Save those investors

Good to know, thx!

The criminality surrounding BLUE Sheets data is rampant...

https://www.sec.gov/newsroom/press-releases/2025-5?utm_medium=email&utm_source=govdelivery

https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/472742874_1004087688423643_1614366062036311373_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=833d8c&_nc_ohc=nfcGrMsEIhAQ7kNvgF3nw1U&_nc_zt=23&_nc_ht=scontent-mia3-2.xx&_nc_gid=AZgGdnGS_3zIT8EnJ2PY5KX&oh=00_AYA_PYWQyRmy2OxdvryhKxL8uHQSf69FZtEDZ_CZJ06VFQ&oe=678BF3D

New shares flying everywhere from the looks of the filings. Form 144 filed on January 10th by Atlas Merchant Capital LLC intent to sell 1,241,144 shares. approximate date of sale listed as 01/10/2025. Robert E. Diamond, Triller Chairman of the Board, Chief Executive Officer of Atlas Merchant Capita

Yes, hence I was saying the really numbers will be in a couple quarters from now, August CC will be two full quarters that we have Vyvanse sell numbers.

CC: NASDAC2020

Remember when you said it won't pass $2 again?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174119656

Please say it won't pass $10 again, $30 again and it'll never be over $200. Thanks.

ATLnsider
@ATLnsider
Global future for $NWBO #DCVax dendritic cell vaccine platform could be unlimited if efficacy is proven to be tumor & tissue agnostic for all solid tumor cancers & when combined with checkpoint inhibitors can also effectively treat all blood or liquid cancers. NWBi